Genomic Valley Biotech Limited

Equities

GVBL6

INE574D01010

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-07-03 EDT			5-day change	1st Jan Change
52.7 ^INR	-4.68%		-7.77%	+40.76%

05-09	Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
02-14	Genomic Valley Biotech Limited Announces Appointment of Mrs. Parul Agrawal as an Additional Non-Executive (Non-Independent) Director on the Board with Effect from February 14, 2024	CI

Genomic Valley Biotech Limited Announces Change in Corporate Office Address

February 14, 2024 at 08:20 am

Genomic Valley Biotech Limited announced that at the board meeting held on February 14, 2024, approved change in Corporate Office of the Company from G-74, Pushkar Enclave, Paschim Vihar, Delhi -110063 to I" Floor, Space No.4, Scindia House, Conn aught Circus, New Delhi-110001with immediate effect.

Latest news about Genomic Valley Biotech Limited

Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-09	CI
Genomic Valley Biotech Limited Announces Appointment of Mrs. Parul Agrawal as an Additional Non-Executive (Non-Independent) Director on the Board with Effect from February 14, 2024	02-14	CI
Genomic Valley Biotech Limited Announces Change in Corporate Office Address	02-14	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14	CI
Genomic Valley Biotech Limited Announces Resignation of Mrs. Jyoti Bansal as Non-Executive (Independent) Director of the Company Effective December 14, 2023	12-14	CI
Genomic Valley Biotech Limited Announces Resignation of Parul Agrawal as Non-Executive (Non-Independent) Director and Reconstitution of Committees	11-14	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-14	CI
Genomic Valley Biotech Limited Announces Executive Changes	23-09-30	CI
Genomic Valley Biotech Limited Approves Shifting of Registered Office	23-09-30	CI
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Genomic Valley Biotech Limited Appoints Yogesh Agrawal as Chief Financial Officer	23-06-30	CI
Genomic Valley Biotech Limited Announces Executive Changes	23-06-30	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-29	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-29	CI
Genomic Valley Biotech CFO Steps Down	23-04-02	MT
Genomic Valley Biotech Limited Announces CFO Changes	23-03-31	CI
Genomic Valley Biotech Limited Announces Change in Directorate	23-03-31	CI
Genomic Valley Biotech Limited Announces Resignation of Mr. Pritam as Company Secretary / Compliance Officer	23-03-02	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-10	CI
Genomic Valley Biotech Limited Announces Appointment of Mr. Pritam as Company Secretary and Compliance Officer	22-12-21	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-12	CI
Genomic Valley Biotech Turns to Net Profit in Fiscal Q1	22-07-20	MT
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-20	CI
Genomic Valley Biotech Limited Announces Resignation of Hanurnan Prasad as Company Secretary and Compliance Officer	22-06-23	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-29	CI